Eptifibatide T20203
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Eptifibatide is a potent glycoprotein IIb/IIIa antagonist (GPIIb/IIIa; Kd = 120 nM) that inhibits platelet aggregation. It inhibits ADP-induced citrated blood aggregation (IC50 = 0.11-0.22 _g/ml) in vitro and in vivo (IC50 = 52 _g/ml in porcine plasma). E
CAS nr:
188627-80-7
Purity:
98%
Molecular Weight:
831,96
SMILES:
NC(NCCCC[C@@H]1NC(CCSSC[C@@H](C(N)=O)NC([C@@H]2CCCN2C([C@@H](NC([C@@H](NC(CNC1=O)=O)CC(O)=O)=O)Cc(c[nH]3)c4c3cccc4)=O)=O)=O)=N
Formula:
C35H49N11O9S2
Pathway:
Target:
